LynnRWebsterMD

PubMed

• 2 citations
  Pharmacokinetics of Buprenorphine Buccal Film and Orally-administered Oxycodone in a Respiratory Study: An Analysis of Secondary Outcomes from a Randomized Controlled ...
  Lynn R Webster, Jacqueline Cater, Thomas Smith> ;Pain and Therapy. 2022 Sep 1
• Drug trafficking, good faith, and legal standards to convict: How the United States Supreme Court is about to affect every prescriber in America.
  Lynn R Webster, Ronald W Chapman Ii, Stephen J Ziegler> ;Journal of Opioid Management. 2022 Jun 6
• 9 citations
  Dilemma of Addiction and Respiratory Depression in the Treatment of Pain: A Prototypical Endomorphin as a New Approach.
  Lynn R. Webster, William K Schmidt> ;Pain Medicine. 2020 May 1
• 81 citations
  Clinical, humanistic, and economic burden of osteoarthritis among noninstitutionalized adults in the United States
  Xiaohui Zhao, Drishti Shah, Kavita Gandhi, Wenhui Wei, Nilanjana Dwibedi, Lynn Webster, Usha Sambamoorthi> ;Osteoarthritis and Cartilage. 2019 Nov 1
• 6 citations
  Desmetramadol Has the Safety and Analgesic Profile of Tramadol Without Its Metabolic Liabilities: Consecutive Randomized, Double-Blind, Placebo- and Active Comparator-...
  John A. Zebala, Shawn L. Searle, Lynn R. Webster, Matthew S. Johnson, Aaron D. Schuler, Dean Y. Maeda, Stuart J. Kahn> ;The Journal of Pain. 2019 Apr 18
• Evaluation of the Relative Intranasal Abuse Potential of a Hydrocodone Extended-Release Tablet Formulated with Abuse-Deterrence Technology in Nondependent, Recreationa...
  Lynn Webster, MD> ;National Institutes of Health. 2017 Oct 11
• Uncritical Publication of a Biased Study Leads to Misleading Media Reports.
  Lynn R. Webster> ;Pain Medicine. 2019 Jul 1
• 1 citations
  Relative Oral Bioavailability of an Abuse-Deterrent, Immediate-Release Formulation of Oxycodone, Oxycodone ARIR in a Randomized Study
  Lynn R Webster, Eric R. Kinzler, Carmela Pantaleon, Matthew Iverson, Stefan Aigner> ;Advances in Therapy. 2019 May 7
• 1 citations
  A nasal abuse potential randomized clinical trial of REMOXY® ER, a high-viscosity extended-release oxycodone formulation
  Nadav Friedmann, Michael R Marsman, Annelies W de Kater, Lindsay H. Burns, Lynn R. Webster> ;Journal of Opioid Management. 2018 Nov 1
• 4 citations
  Oral methylnaltrexone is efficacious and well tolerated for the treatment of opioid-induced constipation in patients with chronic noncancer pain receiving concomitant ...
  Lynn R Webster, Robert J Israel> ;Journal of Pain Research. 2018 Oct 23
• 9 citations
  Oral methylnaltrexone does not negatively impact analgesia in patients with opioid-induced constipation and chronic noncancer pain.
  Lynn R Webster, Robert J Israel> ;Journal of Pain Research. 2018 Aug 13
• Loss of Trust and Empathy Ends an Era of Opioid Self-Assessment.
  Lynn R. Webster> ;Pain Medicine. 2018 Jul 1
• 52 citations
  Long-term use of naldemedine in the treatment of opioid-induced constipation in patients with chronic noncancer pain: a randomized, double-blind, placebo-controlled ph...
  Lynn R. Webster, Srinivas Nalamachu, Bart Morlion, Jyotsna Batapati Krishna Reddy, Yuko Baba, Tadaaki Yamada, Juan Camilo Arjona Ferreira> ;Pain. 2018 May 1
• 5 citations
  A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Intranasal Human Abuse Potential Study of Oxycodone ARIR, a Novel, Immediate-Release, Abuse-Deterrent For...
  Lynn R. Webster, Matthew Iverson, Carmela Pantaleon, Michael D. Smith, Eric R. Kinzler, Stefan Aigner> ;Pain Medicine. 2019 Apr 1
• 9 citations
  Treatment with Naloxegol Versus Placebo: Pain Assessment in Patients with Noncancer Pain and Opioid-Induced Constipation.
  Lynn R. Webster, Ulysses Diva, Raj Tummala, Mark Sostek> ;Pain Practice. 2018 Apr 1
• 2 citations
  Human abuse potential studies of abuse-deterrent opioids: lessons from oral and intranasal studies with morphine abuse-deterrent, extended-release, injection-molded ta...
  Lynn R. Webster, Eugene R. Viscusi, Colville Brown, Jeffrey M. Dayno> ;Current Medical Research and Opinion. 2018 Feb 8
• 15 citations
  Use of an algorithm applied to urine drug screening to assess adherence to an OxyContin® regimen
  Joseph E. Couto, Lynn R. Webster, Martha C. Romney, Harry Leider, Ariel Linden> ;Journal of Opioid Management. 2018 Jan 29
• Analysis of Nausea in Clinical Studies of Lubiprostone for the Treatment of Constipation Disorders.
  Cryer, B.,Drossman, D. A.,Chey, W. D.,Webster, L.,Habibi, S.,Wang, M.> ;Dig. Dis. Sci.. 2017 Aug 30
• 40 citations
  Rational Urine Drug Monitoring in Patients Receiving Opioids for Chronic Pain: Consensus Recommendations.
  Charles E. Argoff, Daniel P. Alford, Jeffrey Fudin, Jeremy A Adler, Matthew J. Bair, Richard C. Dart, Roy Gandolfi, Bill H. McCarberg, Steven P. Stanos, Jeffrey A Gudi...> ;Pain Medicine. 2018 Jan 1
• 2 citations
  Pharmacokinetics and Abuse Potential of Benzhydrocodone, a Novel Prodrug of Hydrocodone, After Intranasal Administration in Recreational Drug Users.
  Mickle, T. C., Mickle, T. C., Mickle, T. C., Mickle, T. C., Guenther, S. M., Guenther, S. M., Guenther, S. M., Guenther, S. M., Barrett, A. C., Barrett, A. C., Barrett...> ;Pain medicine (Malden, Mass.). 2017 Nov 2
• 245 citations
  Risk Factors for Opioid-Use Disorder and Overdose.
  Lynn R. Webster> ;Anesthesia and Analgesia. 2017 Nov 1
• Human Abuse Potential of the New Opioid Analgesic Molecule NKTR-181 Compared with Oxycodone.
  Webster, L., Webster, L., Webster, L., Henningfield, J., Henningfield, J., Henningfield, J., Buchhalter, A. R., Buchhalter, A. R., Buchhalter, A. R., Siddhanti, S., Si...> ;Pain medicine (Malden, Mass.). 2017 Mar 25
• 43 citations
  A Phase 2b, Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Naldemedine for the Treatment of Opioid-Induced Constipation in Pa...
  Lynn R. Webster, Tadaaki Yamada, Juan Camilo Arjona Ferreira> ;Pain Medicine. 2017 Dec 1
• 20 citations
  Current and future development of extended-release, abuse-deterrent opioid formulations in the United States
  Lynn R. Webster, John D. Markman, Edward J. Cone, G. Niebler> ;Postgraduate Medicine. 2017 Jan 2
• 8 citations
  Abuse Potential with Oral Route of Administration of a Hydrocodone Extended-Release Tablet Formulated with Abuse-Deterrence Technology in Nondependent, Recreational Op...
  Mona Darwish, Mary Bond, Yuju Ma, William Tracewell, Philmore Robertson, Lynn R. Webster> ;Pain Medicine. 2017 Jan 1
• Join now to see all